Naoto Ueno
Director · University of Hawaii at Manoa
Credentials: · · · · · · ·
History
2024–Present
- 1992–1994
Medical Oncology
- 1989–1992
Internal Medicine
- 1985–1989
Doctor of Medicine
Research
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
New England Journal of Medicine · 2022 · 2,268 citations
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Nature · 2016 · 1,757 citations
Annals of Oncology · 2021 · 855 citations
Gabriel Hortobagyi
103 papers
98 papers · 1 as a resident
85 papers
68 papers
56 papers · 22 as a fellow
56 papers
53 papers
42 papers
Grants
- 2026–2031
CD44 Splice Variants as Novel Antibody-Targets for Advanced Breast Cancer
National Cancer Institute · R01
PI · $668.9K · University of Texas at Austin
- 1997–2029
University of Hawaii Cancer Center CCSG
National Cancer Institute · P30
Contact PI · $11.2M · University of Hawaii at Manoa
- 2023–2028
Developing a Novel Combination Immunotherapy for Triple-Negative Breast Cancer
National Cancer Institute · R01
Contact PI · $2.6M · University of Hawaii at Manoa
- 2022–2027
Development of a Novel Therapy Targeting the Tumor Microenvironment in Inflammatory Breast Cancer
National Cancer Institute · R01
Contact PI · $3.2M · University of Hawaii at Manoa
Clinical trials
- 2020–2022
Droplet-BC Screening Test for the Detection of Breast Cancer, the DROPLET-BC Study
Principal investigator · Unknown
Preferred Medicine, Inc
- 2018–2019
Harvest of CTCs From MBC Patients Using the Parsortix™ PC1 System
Principal investigator · Completed
Angle plc
- 2016–2021
Principal investigator · Terminated · Phase 2
M.D. Anderson Cancer Center
- 2015–2019
Nintedanib For HER2-Negative Metastatic Inflammatory Breast Cancer (MIBC)
Principal investigator · Terminated · Phase 2
M.D. Anderson Cancer Center